Advanced Neuromodulation Systems To Release Third Quarter Results Thursday, October 28, 2004; WebCast Set For 11:00 a.m. EDT.DALLAS -- Advanced Neuromodulation Systems, Inc. (ANS (ANS Communications, Inc, Purchase, NY) An ISP, Internet backbone and provider of private data network services, founded in 1990 as Advanced Network & Services, Inc., by IBM, MCI and Merit (consortium of Michigan universities). ) (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ANSI (American National Standards Institute, New York, www.ansi.org) A membership organization founded in 1918 that coordinates the development of U.S. voluntary national standards in both the private and public sectors. It is the U.S. member body to ISO and IEC. ) will release financial results for the third quarter ended September 30, 2004 at approximately 7:45 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT on Thursday, October 28, 2004. ANSI has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter. A simultaneous webcast of the conference call may be accessed online at www.ANS-medical.com/investors/index.html. A replay will be available after 1:00 p.m. EDT at this same Internet address. For a telephone replay, dial (800) 633-8284, reservation #21209796, after 1:00 p.m. EDT. About Advanced Neuromodulation Systems (ANS) Advanced Neuromodulation Systems, Inc (NASDAQ:ANSI) designs, develops, manufactures and markets implantable systems used to manage chronic intractable pain intractable pain Refractory pain Pain medicine Persistent pain which does not respond to at least 3 dosease of parenteral analgesics given over a 12-24 hr period; pain that does not respond to appropriate doses of opioid analgesics. and other disorders of the central nervous system. A technology leader in the neuromodulation industry, ANS offers a family of proprietary neurostimulation devices and implantable drug pumps for an expanding range of therapeutic applications. ANS was recently named among FORTUNE's 100 Fastest Growing Companies and has been recognized among Forbes' 200 Best Small Companies for two consecutive years. Frost & Sullivan also recently honored the company with its Product Innovation Award. Additional information is available at www.ans-medical.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion